The complexity of protective immunity against liver-stage malaria

Journal of Immunology

Volumn 165, Issue 3, 2000, Pages 1453-1462

  Doolan, Denise L ^a,b   Hoffman, Stephen L ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b PAN AMERICAN HEALTH ORGANIZATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; MALARIA VACCINE; RECOMBINANT VACCINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; DRUG DELIVERY SYSTEM; FEMALE; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; LIVER; MALARIA; MOUSE; NONHUMAN; PLASMODIUM; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034254649     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.3.1453     Document Type: Article

References (46)

1. World Health Organization. 1994. Malaria Fact Sheet No. 94. World Health Organization, Geneva, Switzerland.
2. Nussenzweig, V., and R. S. Nussenzweig. 1989. Rationale for the development of an engineered sporozoite malaria vaccine. Adv. Immunol. 45:283.
3. Hoffman, S. L., E. D. Franke, M. R. Hollingdale, and P. Druilhe. 1996. Attacking the infected hepatocyte. In Malaria Vaccine Development, S. L. Hoffman, ed. ASM Press, Washington D.C., p. 35.
4. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-defident mice. Nature 369:31.
5. Heusel, J. W., R. L. Wesselschmidi, S. Shresta, J. H. Russell, and T. J. Ley. 1994. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76:977.
6. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
7. Laubach, V. E., E. G. Shesely, O. Smithies, and P. A. Sherman. 1995. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. USA 92:10688.
8. Ozaki, L. S., R. W. Gwadz, and G. N. Godson. 1984. Simple centrifugation method for rapid separation of sporozoites from mosquitoes. J. Parasitol. 70:831.
9. + T cells. J. Immunol. 163:884.
10. Sedegah, M., R. C. Hedstrom, P. Hobart, and S. L. Hoffman. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91:9866.
11. + T cell. interferon-γ, and nitric oxide dependent immunity. J. Exp. Med. 183:1739.
12. Doolan, D. L., R. C. Hedstrom, W. O. Rogers, Y. Charoenvit, M. Rogers, P. de la Vega, and S. L. Hoffman. 1996. Characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii: homolog of P. falciparum exported protein-1. J. Biol. Chem. 271:17861.
13. Hedstrom, R. C., D. L. Doolan, R. Wang, A. Kumar, J. B. Sacci, Jr. M. J. Gardner, J. Aguiar, Y. Charoenvit, M. Sedegah, J. Tine, et al. 1998. In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines. Int. J. Mol. Med. 2:29.
14. Charoenvit, Y., M. L. Leef, L. F. Yuan, M. Sedegah, and R. L. Beaudoin. 1987. Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite-specific antigens. Infect. Immun. 55:604.
15. Charoenvit, Y., S. Mellouk, M. Sedegah, T. Toyoshima, M. F. Leef, P. de la Vega, R. L. Beaudoin, M. Aikawa, V. Fallarme, and Hoffman, S. L. 1995. 17 kDa Plasmodium yoelii hepatic and erythrocytic stage protein is the target of protective antibodies. Exp. Parasitol. 80:419.
16. Rogers, W. O., M. D. Rogers, R. C. Hedstrom, and S. L. Hoffman. 1992. Characterization of the gene encoding sporozoite surface protein 2, a protective Plasmodium yoelii sporozoite antigen. Mol. Biochem. Parasitol. 53:45.
17. + T cell-and IFN-γ-dependent elimination of infected hepatocytes. J. Immunol. 157:4061.
18. Weiss, W. R., R. A. Houghlen, M. F. Good, J. A. Berzofsky, L. H. Miller, and S. L. Hoffman. 1990. A CTL epitope on the circumsporozoite protein of P. yoelii. Bull. World Health Organ. 68:99.
19. Valmori, D., A. Pessi, E. Bianchi, and G. Corradin. 1992. Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination. J. Immunol. Methods 149:717.
20. Franke, E. D., G. Corradin, and S. L. Hoffman. 1997. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides. J. Immunol. 159:3424.
21. Dialynas, D. P., D. B. Wilde, P. Marrack, A. Pierres, K. A. Wall, H. W., G. Otten, M. R. Loken, M. Pierres, J. Kappler, and F. W. Fitch. 1983. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GKL5: expression of L3T4a by functional T cell clones appears to correlate with primarily with class II MHC antigen-reactivity. Immunol. Rev. 74:29.
22. Sarmiento, M., A. L. Glasebrook, and F. W. Fitch. 1980. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 125:2665.
23. Cherwinski, H. M., J. H. Schumacher, K. D. Brown, and T. R. Mosmann. 1987. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1229.
24. Wysocka, M., M. Kubin, L. Q. Vieira, L. Ozmen, G. Garotta, P. Scott, and G. Trinchieri. 1995. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25:672.
25. Weiss, W. R., M. F. Good, M. R. Hollingdale, L. H. Miller, and J. A. Berzofsky. 1989. Genetic control of immunity to Plasmodium yoelii sporozoites. J. Immunol. 143:4263.
26. + T cell and IFN-γ dependent protection against marine malaria by immunization with linear synthetic peptides from Plasmodium yoelii HEP17. Infect. Immun. 67:5604.
27. Weiss, W. R., S. Mellouk, R. A. Houghten, M. Sedegah, S. Kumar, M. F. Good, J. A. Berzofsky, L. H. Miller, and S. L. Hoffman. 1990. Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J. Exp. Med. 171:763.
28. Hoffman, S. L., D. Isenbarger, G. W. Long, M. Sedegah, A. Szarfman, L. Waters, M. R. Hollingdale, P. H. van der Miede, D. S. Finbloom, and W. R. Ballou. 1989. Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. Science 244:1078.
29. Hoffman, S. L., D. Isenbarger, G. W. Long, M. Sedegah, A. Szarfman, S. Mellouk, and W. R. Ballou. 1990. T lymphocytes from mice immunized with irradiated sporozoites eliminate malaria from hepatocytes. Bull. World Health Organ. 68:132.
30. Good, M. F., S. Kumar, and L. H. Miller. 1988. The real difficulties for malaria sporozoite vaccine development: nonresponsiveness and antigenic variation. Immunol. Today 9:351.
31. Rammensee, H.-G., K. Falk, and O. Rotzschke. 1993. MHC molecules as peptide receptors. Curr. Opin. Immunol. 5:35.
32. + T cells. J. Exp. Med. 180:353.
33. + T cells and antibodies required for immunity to malaria sporozoites. Nature 330:664.
34. + T lymphocytes from mice immunized with a synthetic malaria peptide. Proc. Natl. Acad. Sci. USA 88:7963.
35. + T cell clones against Plasmodium yoelii liver stages. J. Immunol. 150:1471.
36. Hoffman, S. L., J. A. Berzofsky, D. Isenbarger, E. Zeltser, W. R. Majarian, M. Gross, and W. R. Ballou. 1989. Immune response gene regulation of immunity to Plasmodium berghei sporozoites and circumsporozoite protein vaccines: overcoming genetic restriction with whole organism and subunit vaccines. J. Immunol. 142:3581.
37. Yoneto, T., T. Yoshimoto, C.-R. Wang, Y. Takahama, M. Tsuji, S. Waki, and H. Nariuchi. 1999. γ-Interferon production is critical for protective immunity to infection with blood-stage Plasmodium berghei XAT but neither NO production nor NK cell activation is critical. Infect. Immun. 67:2349.
38. Doolan, D. L., B. Wizel, and S. L. Hoffman. 1996. Class I restricted cytotoxic T lymphocyte responses against malaria - elucidation on the basis of HLA peptide binding motifs. Immunol. Res. 15:280.
39. Berke, G. 1995. The CTL's kiss of death. Cell 81:9.
40. Renggli, J., M. Hahne, H. Matile, B. Betschart, J. Tschopp, and G. Corradin. 1997. Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-I) or perforin-mediated cytotoxicity. Parasite Immunol. 19:145.
41. Clark, W. R., C. M. Walsh, A. A. Glass, M. T. Huang, R. Ahmed, and M. Matloubian. 1995. Cell-mediated cytotoxicity in perforin-less mice. Int. Rev. Immunol. 13:1.
42. + T cells clear influenza virus by perform or Fas-dependent processes. J. Immunol. 159:5197.
43. + T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 159:105.
44. Matloubian, M., M. Suresh, A. Glass, M. Galvan, K. Chow, J. K. Whitmire, C. M. Walsh, W. R. Clark, and R. Ahmed. 1999. A role for perform in downregulating T-cell responses during chronic viral infection. J. Virol. 73:2527.
45. + T cells by perform. Eur. J. Immunol. 29:3262.
46. Sambhara, S., I. Switzer, A. Kurichh, R. Miranda, L. Urbanczyk, O. James, B. Underdown, M. Klein, and D. Burt. 1998. Enhanced antibody and cytokine responses to influenza viral antigens in perforin-deficient mice. Cell. Immunol. 187:13.